Suchergebnisse - (Subject:"Immunologic Factors")

PubPharm (5)

1

Clinical review report : indication : indicated for the treatment of patients aged 12 years and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisableDupilumab (Dupixent) (Sanofi genzyme, a division of Sanofi-Aventis Canada Inc.)

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, June 2020

CADTH common drug review

Version: Final.

2

Intravenous immunoglobulins for refractory status epilepticus, part I : A scoping systematic review of the adult literature

enthalten in: Seizure | 2017

von Zeiler, F. | Matuszczak, M. | Teitelbaum, J. | +2

3

Hemophagocytic lymphohistiocytosis : Analysis of 18 cases

enthalten in: Medicina clinica | 2016

von Hernández-Jiménez, P. | Díaz-Pedroche, C. | Laureiro, J. | +3

4

Eculizumab for atypical hemolytic-uremic syndrome

enthalten in: The New England journal of medicine | January 29, 2009

von Nürnberger, J. | Philipp, T. | Witzke, O. | +8

5

Seroepidemiological correlations of antibodies to human herpesviruses and human immunodeficiency virus type 1 in African patients

enthalten in: European journal of epidemiology | 1991

von Essers, S. | Schwinn, A. | ter Meulen, J. | +5

1
[1]